QuarterHawk — Equity ResearchQuarterHawk — Equity Research

Carlyle Secured Lending, Inc. (CGBD)

Financial Services

No action
Fundamental
3
Sentiment
2
Technical
3

Do Nothing: qualitativeScore is 2 (below the required floor of 3) and the 20-day average dollar volume of $4.61M is below the $5.0M liquidity floor; both a pullback limit near 10.93 (R/R ≈1.93) and a breakout buy-stop at 11.46 (R/R ≈2.00) were evaluated and neither is admissible.

Analysis as of 2026-11-14· more than 2 trading days ago

Company overview

Carlyle Secured Lending, Inc. is a business development company focused on direct investments in middle-market companies. It offers a range of financing solutions including senior secured loans, unsecured debt, mezzanine debt, and equity stakes, targeting industries such as healthcare, technology, and real estate across the U.S. and select international markets.

Fundamental

fair
Fundamental3
Mixed fundamentals

Carlyle Secured Lending shows mixed fundamentals with sound leverage but deteriorating credit quality and NAV erosion.

Mixed fundamentals: a diversified $2.34 billion first-lien-weighted BDC with comfortable leverage (1.20x net), $598 million of liquidity, all covenants in compliance and a 12.6% dividend yield now covered by net investment income, offset by deteriorating credit (non-accruals up from 7 to 11 investments during 2026), NAV erosion from $16.99 to $15.65, a 12.5% dividend cut and a persistent roughly 29% discount to NAV. Not distressed, but the risk is skewed to the downside over a short horizon.

Sentiment

weak
Sentiment2
Weak sentiment

Sentiment is weak with a net-negative Q3 earnings impact and no significant catalysts in the near term.

CGBD's dominant near-term driver is the Q3 2026 earnings print (2026-11-05, announced), which the tape scored net-negative — NII/EPS of $0.36 landed a penny under consensus and the call flagged a YoY decline in direct-lending volume — and media polarity deteriorated modestly but determinately from a near-flat 90-day baseline (polarity_score ≈ -0.01 across 4 scored items) to ≈ -0.17 across 3 scored items in the last 14 days, only partly offset by a Raymond James price-target raise on JV growth. Retail is indeterminate (Reddit access blocked), the legal screen surfaced no regulator-confirmed or law-firm matters, and a moderate red-flag cap applied for conflicting catalyst signals; with no forward-dated catalyst inside 30 days the evidence sits on the weak side of mixed rather than genuinely balanced.

Technical

fair
Technical3
Constructive recovery

The technical outlook is constructive with price above key moving averages, though trend strength is weak.

CGBD is a recovering BDC at 11.08, holding above its SMA20 (10.75), SMA50 (10.91) and marginally above a still-flat SMA200 (11.07), with a positive MACD (line 0.15 > signal 0.08 > 0, histogram +0.07) and a neutral RSI14 of 54.90 — a constructive but low-conviction picture: ADX14 is only 18.52, and price has slipped back below the short-term stack (EMA9 11.11, WMA9 11.20, DEMA14 11.23, TEMA14 11.36) after a three-session pullback from the 11.44 high of 2026-11-10. ATR14 of 0.28 (2.53% of price) is ample for an ATR-scaled swing, but the chart is not the binding constraint: qualitativeScore of 2 is below the required floor of 3 (hard block) and 20-day average dollar volume of ~$4.61M sits under the $5M liquidity floor, so no entry is admissible despite a decent technical read.

You’re looking at 2026-11-14 — more than 2 trading days ago.

Subscribers saw this then, and see today’s score, verdict and trade plan now.

Not financial advice. For informational and educational purposes only.